Point-Counterpoint: Radioisotope-guided lymphadenectomy for pelvic node staging: The SENTINELLE study Editorial

   

Authors:	Perera, M.; Touijer, K. A.
Title:	Point-Counterpoint: Radioisotope-guided lymphadenectomy for pelvic node staging: The SENTINELLE study
Keywords:	unclassified drug; cancer patient; cancer staging; positron emission tomography; lymph node dissection; pelvis lymph node; lymph nodes; neoplasm staging; technetium 99m; sensitivity and specificity; lymph node excision; sentinel lymph node biopsy; morbidity; editorial; diagnostic imaging; high risk patient; cancer hormone therapy; prostate cancer; prostatic neoplasms; prostate specific membrane antigen; diagnostic value; prostatectomy; lymph node; surgery; open study; tracer; radioisotope; lymphatic drainage; radioisotopes; adjuvant radiotherapy; biochemical recurrence; predictive value; bone scintiscanning; standardized uptake value; randomized controlled trial (topic); intermediate risk patient; single photon emission computed tomography; indocyanine green; humans; human; male; x-ray computed tomography; gallium 68 psma-11; prostate specific membrane antigen ga 68; nanocolloid; intraprostatic drug administration
Journal Title:	Journal of Urology
Volume:	210
Issue:	2
ISSN:	0022-5347
Publisher:	Elsevier Science, Inc.
Date Published:	2023-08-01
Start Page:	244
End Page:	246
Language:	English
DOI:	10.1097/ju.0000000000003494
PUBMED:	37192376
PROVIDER:	scopus
PMCID:	PMC10330182
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164274078&doi=10.1097%2fJU.0000000000003494&partnerID=40&md5=6a055a6c2c36dbde90fa4f62489f0013
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/208106